As well as TOX is doing fundamentally, its PR record has been...

As well as TOX is doing fundamentally, its PR record has been disgraceful this year.

Im sure TOX will record EBITDA of $4.8million this financial year but had there been more investor presentations this year, a few more progress reports to shareholders and a bit more enthusiasm by the comopany coming from the quarterly reports and less dribble, the share price would be at the very least 20c at the moment.

The integration of Delvex has been a huge success on the bottom line.

I know the saying goes wealth is transferred from the impatient ot the patient. However, the last six months has been an enormous opportunity cost holding TOX.

I would also like to see the directors acquiring some stock at the current levels. I have never seen any directors of TOX buy on market. If there is ever a time to advise the market that TOX is heavily undervalued, it is now.

I am a long term supporter of TOX and will continue to be. I just know TOX can do better than what the share price is showing at the present.

Cheers